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Summary
Objective: Adipose tissue-derived mesenchymal stem cells (ATMSCs) have been shown to differentiate into bone, cartilage, fat or muscle.
However, it is not certain that ATMSCs are equal to bone marrow-derived mesenchymal stem cells (BMMSC) for their bone and cartilage
forming potential. The purpose of this study was to answer the question.
Methods: BMMSCs were obtained from the medullary canal of femur and ATMSCs were isolated from the fat harvested during liposuction
procedures. After cell expansion in culture media and two passages, the immunoﬂuorescent studies for STRO-1 and CD34 were performed to
characterize the BMMSCs and ATMSCs. Osteogenesis was induced on a monolayer culture with osteogenic medium containing
dexamethasone, b-glycerophosphate and ascorbate. After 2e3 weeks, alkaline phosphatase (AP) and Von Kossa staining were done. To test
for chondrogenesis, mesenchymal stem cells (MSCs) were cultured in a pellet culture and in a ﬁbrin scaffold with a chondrogenic medium
(CM) containing transforming growth factor-b2 and insulin-like growth factor-I. After 4 weeks, Safranin-O staining and immunohistochemical
staining for type II collagen were done to evaluate the chondrogenic differentiation and the matrix production. A histological scale was used to
semiquantitatively assess the degree of chondrogenesis.
Results: Both BMMSCs and ATMSCs were STRO-1 positive and CD34 negative. On the test of osteogenesis, the osteoblastic differentiation
of ATMSCs as demonstrated by AP staining was much less than that of the BMMSCs (PZ 0.002). The amount of matrix mineralization shown
by Von Kossa staining also showed statistical differences between the two MSCs (PZ 0.011). On the test for chondrogenesis by the pellet
culture ATMSCs showed much weaker presentation as chondrogenic cells in both cell morphology and the matrix production. The histological
score was 6.5 (SD1.3) for the BMMSCs, and 4.3 (SD1.6) for the ATMSCs cultured in CM, which was statistically signiﬁcant (PZ 0.023). The
results from ﬁbrin gel paralleled those from the pellet culture in general.
Conclusion: The results of our study suggest that the ATMSCs may have an inferior potential for both osteogenesis and chondrogenesis
compared with the BMMSCs, and these cast doubts on the value of adipose tissue as a source of MSCs.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.





The loss of musculoskeletal tissue creates a major chal-
lenge to orthopaedic or plastic surgeons. New techniques
involving the implantation of cells and tissue engineered
construct are being developed to improve bone and
cartilage repair1e9. The ideal cell needed for tissue
engineering must be immunocompatible and have a self-
regenerative potential. Multi-lineage stem cells have both
these characteristics, so they possess excellent therapeutic
potential for tissue regeneration1,2,4. Although the use of
embryonic stem cells is appealing because of their
pluripotentiality, their practical use is limited due to ethical
concerns and government regulations10. Mesenchymal
stem cells (MSCs) from adults are highly clonogenic cells
capable of self-regeneration and multi-lineage differentia-
tion into bone, cartilage, fat, and muscle 1,11e13. Recent
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tissue can contribute to the repair of another because of
a previously unrecognized plasticity13. Although bone
marrow provides the most universal source of MSC, other
tissues such as periosteum, muscle, synovial membrane
and adipose tissue also appear to possess MSCs1,14e21.
Adipose tissue is particularly attractive because of its easy
accessibility and abundance20e22.
Adipose tissue-derived mesenchymal stem cells
(ATMSCs) obtained from lipoaspirates have been shown
to have the multi-lineage potential to differentiate into
adipogenic, chondrogenic, myogenic and osteogenic
cells21,23,24. Even a differentiation into the neurogenic
phenotype has been demonstrated as well20. ATMSCs
mineralized their extracellular matrix (ECM), and increased
expression of osteocalcin and alkaline phosphatase (AP)25.
ATMSCs produced cartilage matrix molecules in alginate
culture and also in vivo when implanted subcutaneously in
nude mouse26. However, it is not well established whether
ATMSCs have the same potential for osteogenesis and
chondrogenesis as bone marrow-derived mesenchymal
stem cells (BMMSCs). Thus, the purpose of this study5
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in regards to their bone and cartilage forming potential.
Materials and methods
The materials used in this study were purchased from
Sigma-Aldrich (St. Louis, MO, USA) unless otherwise
speciﬁed.
PROCUREMENT OF SAMPLES
Bone marrow samples used for the isolation of MSCs
(BMMSCs) were obtained from eight patients (mean age:
65 years, range: 52e73 years) undergoing total hip
replacement. The adipose tissue samples used for MSCs
(ATMSCs) were isolated from lipoaspirates generated
during the elective liposuction procedures for six patients
(mean age: 55 years, range: 44e65 years). This study was
approved by the institutional review board of our university,
and an informed consent was obtained from all the
individuals included in the study.
CELL ISOLATION AND CULTIVATION
BMMSCs were isolated from fresh bone marrow samples
as described elsewhere9,11,27,28. Brieﬂy, bone marrow
samples (10 ml) were mixed with 0.3 ml of heparin to
prevent coagulation, and then this was diluted with 20 ml of
phosphate buffered saline (PBS). The cells were fraction-
ated on a Lymphoprep density gradient (Axis-Shield, Oslo,
Norway), by centrifuging at 600 g for 10 min. The interface
mononuclear cells were isolated, and these cells were
washed with PBS, and then erythrocyte (RBC) lysis buffer
(0.154 M NH4Cl, 10 mM KHCO3, 0.1 mM ethylenediamine
tetra-acetic acid (EDTA)) was added to destroy the RBC
contaminants. The cells were washed twice by centrifuga-
tion (600 g) in PBS. One million cells were seeded in F-12/
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) (Gibco BRL,
Green Island, NY, USA) containing 10% fetal calf serum
(FCS: Gibco BRL) and 1% antibiotics (penicillin 100 U/ml,
streptomycin 0.1 mg/ml, amphotericin B 0.25 mg/ml: Gibco
BRL) at 37(C in a humidiﬁed atmosphere with 5% CO2.
The ATMSCs were isolated from lipoaspirate. Brieﬂy, the
lipoaspirates were washed three times with PBS and the
matrix was digested with 1.5 mg/ml collagenase, and then
ﬁltered through a 250-mm nylon mesh. The erythrocytes
were removed using erythrocyte lysis buffer. The remaining
cells were seeded in culture ﬂasks and maintained under
conditions identical to those used for the BMMSCs.
The cells were cultured in DMEM/Ham F-12 supple-
mented with 10% FCS, 1% antibiotics, and the cultures
were maintained at 37(C in a humidiﬁed atmosphere and
5% CO2. After 48 h, the cultures were washed with PBS to
remove the nonadherent material. During the expansion
period, the medium was replaced twice a week. When the
cells had reached 80% of conﬂuence, they were detached
from the culture dish using 0.25% trypsin containing 1 mM
EDTA (Gibco BRL), and they were washed with PBS,
counted and plated again. After culturing through passage
2, the cells were suspended in cryo-preservation medium
containing 90% FCS and 10% dimethylsulfoxide. As there
were differences in the growth kinetics of two types of
MSCs, care was taken to ensure that cells have the same
population doubling in each passage.INVESTIGATION OF CELL MARKER BY IMMUNOFLUORESCENT
STAINING
As the isolation of MSCs was solely based on the
adherence on plastic surface, immunoﬂuorescent stainings
for cell surface antigens were done in order to further
characterize the cells29. STRO-1, a cell surface antigen
used to select for multipotential bone marrow stromal cell,
and CD34, a cell surface marker of hematopoietic lineage
cells, were investigated. Cells on the passage 3 were plated
on eight-well chamber slides on the density of 105 cells per
chamber, and grown until they reached conﬂuence. They
were washed with 0.01 M PBS three times and then ﬁxed
with absolute methanol at 20(C for 20 min. They were
next washed with 0.01 M PBS three times for 5 min each in
a shaker and then incubated with 0.2% Triton X-100 in PBS
for 20 min at room temperature; this was followed by
incubation with 10% goat serum in PBS for 1 h at room
temperature. Primary antibodies of STRO-1 (R&D systems,
Minneapolis, MN, USA) and CD34 (Lab Vision-Neo-
markers, Fremont, CA, USA) were applied for 1 h at
37(C, and then washed with 0.01 M PBS three times for
5 min each in shaker. FITC-labeled secondary antibody
(goat anti-mouse: Zymed, CA, USA) was applied for 1 h at
37(C, then washed with PBS. The slides were then
mounted and examined with confocal microscopy. Mono-
nuclear cells isolated from human peripheral blood were
used as negative control for STRO-1 and positive control for
CD 34.
INDUCTION OF OSTEOGENIC DIFFERENTIATION
The ATMSCs and BMMSCs at passage 3 were analyzed
for their capacity to differentiate toward the osteogenic
pathway. To induce differentiation, the ATMSCs and
BMMSCs were cultured with speciﬁc induction media. The
osteogenic medium (OM) was composed of DMEM/F-12
solution containing 1% FCS, 0.1 mM dexamethasone,
50 mM ascorbate-2-phosphate, 10 mM b-glycerophosphate,
1% antibiotic/antimycotic. DMEM/F-12 solution containing
1% FCS, 1% antibiotic/antimycotic was used as the control
medium for each condition.
The cells were incubated in OM for 2e3 weeks in a 12-
well plate at the density of 105 cells per well, and they were
then examined for osteoblastic differentiation by AP
staining, and for the ECM calciﬁcation by Von Kossa
staining. To detect AP activity, the cells were rinsed with
PBS and ﬁxed with citrateeacetoneeformaldehyde solution
for 30 s at room temperature. The cells were rinsed with
distilled water, and then incubated in an alkaline-dye
mixture (0.08 mg/ml Naphthol AS-BI phosphate, 0.1 mg/ml
Fast blue BB base; Sigma-Aldrich) at room temperature
for 15 min. The cells were washed several times with
distilled water and counterstained with 0.5% neutral red
solution. For Von Kossa staining, the cells were ﬁxed with
4% paraformaldehyde for 1 h at room temperature. The
cells were rinsed with distilled water and then overlaid with
a 1% (w/v) silver nitrate solution in the absence of light for
30 m. The cells were washed several times with distilled
water and then developed under UV light for 1 h. Finally, the
cells were counterstained with 0.1% eosin in ethanol.
The specimens were then reviewed with a microscope.
The percentage of positive cells was obtained with AP
staining and the number of mineralization nodules was
counted in Von Kossa staining, both by examining 5 high
power ﬁelds.
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Three-dimensional pellet and fibrin gel culture
For the induction of chondrogenesis in three-dimension,
both pellet culture and ﬁbrin gel culture were used. For the
pellet culture, passaged MSCs were centrifuged at 500 g for
5 min. Cells were resuspended at a density of 1! 106 cells/
ml in DMEM/F-12 medium supplemented with 1% insulin-
transferrin-selenium (ITS) (Gibco BRL), 107 M dexameth-
asone, 50 mM ascorbate-2-phosphate, 50 mM L-proline,
1 mM sodium pyruvate. One milliliter of cell suspension
was aliquoted into 15 ml polypropylene centrifuge tubes,
then spun in a benchtop centrifuge at 500 g for 5 min. Then,
5 ng/ml of transforming growth factor (TGF)-b2 (R&D
Systems), and 100 ng/ml of insulin-like growth factor
(IGF)-I (R&D Systems) were added to the medium. This
combination constituted chondrogenic medium (CM) and
the medium without growth factors was used as the control
medium. The tubes were placed in the incubator at 37(C in
a humidiﬁed atmosphere of 95% air and 5% CO2 for up to 4
weeks. The caps of the tubes were loosened to allow air
exchange. Medium was changed every third day. For ﬁbrin
gel culture, ATMSC and BMMSC suspension at the
passage 3 were recovered and centrifuged. The cell pellets
were resuspended in equine ﬁbrinogen (200 mg/ml) to form
a mixture containing 1! 107 cells/ml and 2 TIU/ml of
aprotinin. Each ﬁbrin disk was polymerized by combining
0.25 ml calcium activated bovine thrombin with 0.25 ml of
the ﬁbrinogenecell suspension19. The resulting three-di-
mensional ﬁbrin disk contained 100 U of thrombin, 100 mg
of ﬁbrinogen, 2.5! 106 cells and 0.5 TIU of aprotinin in
a total culture volume of 0.5 ml. The disk thickness was
4 mm. Disks were covered with 0.5 ml of the same CM as
used in the pellet culture. The disks were cultured in the
incubator at 37(C in a humidiﬁed atmosphere of 95% air
and 5% CO2 for up to 4 weeks. Fresh medium was added
every third day.
Histological analysis
After 4 weeks of culture, the pellets and the ﬁbrin disks
were ﬁxed in 4% formaldehyde solution for 3 h, then
dehydrated with 100% ethanol, washed with xylene, and
then embedded with parafﬁn. Sections with a thickness of
4 mm were cut from the parafﬁn block and coated on the
glass slide. Safranin-O staining was performed to assess
the degree of proteoglycan synthesis. The tissue sections
were deparafﬁnized with xylen and ethanol. Then 1%
aqueous Safranin-O was added for 30 min, and washed
with distilled water; 0.2% fast green was added for 3 min,
then the sections were washed with distilled water and with
serial concentration of 70%, 80%, and 95% ethanol. The
immunohistochemical staining for type II collagen was
performed to test if the cells function as chondrocytes.
The tissue sections were deparafﬁnized, treated with trypsin
for 15 min, then 3% hydrogen peroxide was added to
suppress the endogenous peroxidase activity. Polyclonal
antibody against type II collagen (Chemicon, Temecula,
CA, USA) was allowed to react with the tissue section at the
room temperature for 1 h. Then biotinylated anti-mouse
antibody (Zymed) was added for 30 min, and then
streptavidin peroxidase (Dako, Glostrup, Denmark) was
applied. 3-Amino-9-ethylcarbazole was used as chromo-
genic agent and counterstaining was done with Mayer’s
hematoxylin. A semiquantitative scoring system modiﬁed
from that used by Grogan et al.30 was used to evaluate and
compare the difference in the degree of chondrogenesisfrom the pellet culture (Table I). It evaluates the neo-
cartilage in three categories: (1) the uniformity and
darkness of Safranin-O stain and immunohistochemical
stain for type II collagen; (2) the distance between cells and
the amount of matrix produced; (3) the cell morphology
represented. Each category has scores ranging from 0 to 3,
higher scores indicating satisfactory chondrogenesis. When
there is a discrepancy in the Safranin-O and type II collagen
staining, their average score was used for the ﬁrst category.
Normal human articular cartilage with subchondral bone
from femoral head was used as the control for the staining.
STATISTICAL ASSESSMENT
Statistical analysis was carried out by the ManneWhitney
U test. Statistical signiﬁcance was indicated by P values
!0.05.
Results
CULTIVATION AND PASSAGING OF HUMAN MESENCHYMAL
STEM CELL CULTURES
Nonadherent cells were removed from the dish during
medium changes and the subsequent passaging. Typically,
80e90% of conﬂuence was reached by day 14 in BMMSC
cultures and by day 10 for the ATMSC culture. Cells at the
third passage were used for the experiments.
CHARACTERIZATION OF MSCs BY IMMUNOFLUORESCENCE
The results from passage 3 cells showed that almost all
of the BMMSCs and ATMSCs were STRO-1 positive
although the intensity of STRO-1 was stronger for the
BMMSCs; the signals for CD34 were very faint in both
BMMSCs and ATMSCs while the peripheral blood mono-
cytes that were used as the control were very weakly
positive for STRO-1 and strongly positive for CD34. This
conﬁrmed that the passage 3 cells derived from both bone
marrow and adipose tissue had chracteristics of MSCs and
Table I
The semiquantitative histological grading system to evaluate tissue
engineered cartilage
Scoring categories Score
1. Uniformity and darkness of Safranin-OeFast
Green stain and immunohistochemical staining
for type II collagen
No Stain 0
Weak staining of poorly formed matrix 1
Moderately even staining 2
Even dark stain 3
2. Distance between cells/amount of matrix
produced
High cell densities with no matrix in between 0
High cell densities with little matrix in between 1
Moderate cell density with little matrix 2
Low cell density with moderate distance between
cells and an extensive matrix
3
3. Cell morphologies represented
Condensed/necrotic/pycnotic bodies 0
Spindle/ﬁbrous 1
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(Fig. 1).
DIFFERENCES IN OSTEOGENESIS
Induction of AP activity
After 2 weeks of culture in OM, MSC cultured with OM
underwent a change in cellular morphology from spindle-
shape to a more polygonal appearance accompanied by
a signiﬁcant increase in AP activity. BMMSCs underwent
a much higher increase in AP activity compared with
ATMSCs (Fig. 2). After 3 weeks of culture, the AP activity
further increased, and the difference between BMMSCs
and ATMSCs was still detectable. There were signiﬁcant
differences in the number of positive cells after both 2
weeks and 3 weeks (PZ 0.002, Table II).
Von Kossa staining
After 2 weeks of culture, mineralization was barely
detectable in either the BMMSCs or ATMSCs. After 3
weeks, mineralizing nodules were detectable in both
BMMSCs and ATMSCs. The mineralization was more
marked in BMMSCs compared with ATMSCs although the
difference was less prominent than with the AP staining
(Fig. 3). However, there was a statistically signiﬁcant
difference in the number of mineralization nodules
(PZ 0.011, Table II).DIFFERENCES IN CHONDROGENESIS
On the three-dimensional ﬁbrin culture, the appearances
of cells were of similarly round shape although the ATMSCs
are more conglomerated (Fig. 4).
The cells after 4 weeks of pellet culture did not have the
appearance of chondrocytes although the area of low
density with abundant ECM was found in BMMSCs treated
with CM [Fig. 5(A, B)]. These appearances were not found in
ATMSCs treated with CM [Fig. 5(C, D)]. Safranin-O staining
showed distinct proteoglycan production in BMMSCs
treated with CM compared to BMMSCs grown in the control
medium [Fig. 5(E, F)]. However, the treatment with CM did
not lead to such a difference in ATMSCs [Fig. 5(G, H)]. This
pattern was quite similarly reproduced in the immunohisto-
chemical staining for type II collagen [Fig. 5(JeM)]. The
histological score was 6.5 (SD1.3) for the BMMSCs cultured
in CM, and 4.3 (SD1.6) for the ATMSCs treated with CM,
which was statistically signiﬁcant (PZ 0.023).
In ﬁbrin gel culture, the shape of BMMSCs was round and
looked like chondrocytes in lacunae [Fig. 6(A)]. When TGF-
b2 and IGF-I were not given, fewer cells were found and the
size of the cells was smaller [Fig. 6(B)]. ATMSCs were
found in large number in the scaffold. However, only a small
percentage of cells had round shape, located in lacuna-like
structure [Fig. 6(C, D)]. BMMSCs cultured in the CM
showed a considerable degree of metachromasia, espe-
cially at the pericellular area [Fig. 6(E)]. Without TGF-b2 and
IGF-I, the metachromatic staining appeared much fainter
[Fig. 6(F)]. ATMSCs had metachromatic staining on theFig. 1. Immunoﬂuorescent staining for STRO-1 in BMMSCs (A); ATMSCs (B); peripheral blood monocyte (C), and CD34 in BMMSCs (D);
ATMSCs (E); peripheral blood monocyte (F).
849Osteoarthritis and Cartilage Vol. 13, No. 10Fig. 2. AP staining of BMMSCs after 2 weeks of culture in OM (A); control medium (B), and ATMSCs after 2 weeks of culture in OM (C); control
medium (D).matrix, but this lacked the strong pericellular staining
observed with the BMMSCs [Fig. 6(G)]. Without TGF-b2
and IGF-I, metachromatic staining of matrix was hardly
observed in the ATMSCs [Fig. 6(H)]. In the immunohisto-
chemical staining for type II collagen of the BMMSCs
cultured in CM, the expression was generalized throughout
the matrix with a stronger pericellular expression [Fig. 6(I)].
Even without TGF-b2 and IGF-I, some degree of positive
staining was observed [Fig. 6(J)]. For the ATMSCs, very
weak staining was observed irrespective of growth factor
administration [Fig. 6(K, L)].
Discussion
Although bone marrow provides a universal source of







nodules per high power ﬁeld
after 3 weeks of culture in OM
2 weeks 3 weeks
BMMSCs
(nZ 8)
85 (2)% 92 (3)% 4.2 (0.9)
ATMSCs
(nZ 6)
28 (4)% 45 (4)% 2.8 (0.6)
P-value 0.002* 0.002* 0.011*
Standard deviations are given in parenthesis. *P! 0.05.accessible MSCs. Recent advances in cosmetic surgery
add to its advantage with huge amount of available fatty
tissue. It may have a further advantage when the morbidity
associated with large volume bone marrow harvests is
taken into the consideration31,32.
Zuk et al.20 ﬁrst identiﬁed that ﬁbroblast-like cell obtained
from lipoaspirate could differentiate into adipogenic, chon-
drogenic, myogenic and osteogenic cells under appropriate
medium conditions. However, it was not certain from their
study that the ATMSCs have the same capacity for tissue
regeneration as BMMSCs. Subsequent studies have
suggested that there might be differences in the cellular
characteristics and differentiation potential between
BMMSCs and ATMSCs18,33. CD marker antigens were
found to differ between BMMSCs and ATMSCs: CD49d
was expressed only in ATMSCs and CD 106 vice
versa20,34. Wickham et al.33 also showed that ATMSCs
isolated from the human patellar fat pad differed from
BMMSCs in the cell surface antigen proﬁle. Winter et al.18
demonstrated that though the multi-lineage potentials of
BMMSCs and ATMSCs are similar in cell morphology and
histology, there were minor differences in the marker gene
expression for the diverse differentiation pathways. An
additional important ﬁnding from their study was that only
the BMMSCs responded to a shift to high-density three-
dimensional cell culture. However, a recent study by de
Ugarte et al.35 that compared cell yield, growth kinetics, cell
senescence and multi-lineage differentiation capacity
showed no signiﬁcant difference between the BMMSCs
and ATMSCs isolated from the same person.
With these unanswered questions and inadequate
informations, the authors tried to compare the osteogenic
850 Gun-II Im et al.: Osteogenic and chondrogenic potential of ATMSCs and BMMSCsFig. 4. The appearance of BMMSCs (A) and ATMSCs (B) in the ﬁbrin culture (5 days after seeding).
Fig. 3. Von Kossa staining of BMMSCs after 3 weeks of culture in OM medium (A); control medium (B), and ATMSCs after 3 weeks of culture
in OM (C); control medium (D).
851Osteoarthritis and Cartilage Vol. 13, No. 10Fig. 5. Chondrogenesis in the pellet culture. Hematoxylin eosin staining of BMMSCs cultured in CM (A); in control medium (B), ATMSCs
cultured in CM (C); in control medium (D) after 4 weeks of culture. Safranin-O staining of BMMSCs in CM (E); in control medium (F), ATMSCs
cultured in CM (G); in control medium (H). Immunohistochemical staining for type II collagen of BMMSCs in CM (J); in control medium (K),
ATMSCs cultured in CM (L); in control medium (M). Normal human articular cartilage and subchondral bone were used as the control for
Safranin-O staining (I) and type II collagen staining (N).and chondrogenic potentials of ATMSCs with those of
BMMSCs. The expression of STRO-1 and CD34 by the
immunoﬂuorescent study illustrated a qualitatively compa-
rable pattern between BMMSCs and ATMSCs.
On test for osteogenesis in vitro, the osteoblastic
differentiation of ATMSCs as demonstrated by AP staining
was less than that of the BMMSCs. The amount of matrix
mineralization shown by Von Kossa staining also showed
statistical differences between the two MSCs. It is sug-
gested that ATMSCs will differentiate into osteoblasts under
the appropriate conditions but less effectively when
compared with the BMMSCs. Our results differ from those
of de Urgarte et al.35 who reported no statistically signiﬁcant
changes in AP activity between BMMSCs and ATMSCs.
They used passage 4 cells and DMEM medium, whereas
we used passage 3 cells and DMEMeF-12 medium. It
could be speculated that ATMSCs may require a more
deﬁned, different medium for an effective osteogenesis.
On test for chondrogenesis by the pellet culture ATMSCs
showed much weaker presentation as chondrogenic cells in
both cell morphology and the matrix production.
The scores from the semiquantitative histological grading
system accordingly demonstrated a signiﬁcant difference
between the two cells. The ﬁbrin gel culture gave another
opportunity to examine the appearance of ATMSCs as
compared to BMMSCs. The results in general paralleledthose from the pellet culture. One interesting point is that
when TGF-b2 and IGF-I were not added, ATMSCs hardly
showed metachromasia whereas BMMSCs had some
proteoglycan production without these factors. This may
mean that ATMSCs were absolutely dependent on these
factors for chondrogenesis while the chondrogenesis per se
was even less perfect with the given amount of growth
factors as compared with the BMMSCs. The overall results
of our study do not corroborate the results of previous
studies that suggested equal or comparable capacity of
ATMSCs for osteogenesis and chondrogenesis20,34,35. Our
results are backed up by a recent study by Yoshimura
et al.36 that showed that bone marrow- or synovium-derived
stem cells had greater chondrogenic and osteogenic
potential than adipose tissue-derived stem cells. Another
study from the same group demonstrated that cells derived
from subcutaneous fat have inferior potential in proliferation
and chondrogenesis to those from infrapatellar fat pad37.
This lends support to the supposition that ATMSCs may
have an inferior potential to differentiate into the cartilage.
However, the authors’ results do not exclude the possibility
that a different combination of growth factors may induce
a more effective chondrogenesis from ATMSCs.
There are limitations of this study that preclude deﬁnite
conclusions. First, we had different donors for BMMSCs
and ATMSCs. The authors had originally planned to get
852 Gun-II Im et al.: Osteogenic and chondrogenic potential of ATMSCs and BMMSCsFig. 6. Chondrogenesis in the ﬁbrin gel culture. Hematoxylin eosin staining of BMMSCs cultured in CM (A); in control medium (B), ATMSCs
cultured in CM (C); in control medium (D) after 4 weeks of culture. Safranin-O staining of BMMSCs in CM (E); in control medium (F), ATMSCs
cultured in CM (G); in control medium (H). Immunohistochemical staining for type II collagen of BMMSCs in CM (I); in control medium (J),
ATMSCs cultured in CM (K); in control medium (L).both bone marrow and adipose tissue from the patients
undergoing total hip arthroplasty. However, we found it
difﬁcult to harvest adequate fatty tissue without causing
a wound problem. Advanced age is known to affect the
proliferation and differentiation potential of MSCs38e41. If we
had got the BMMSCs from the same age group as ATMSC
donors, it would have ampliﬁed the overall differences in the
results between them. Second, the gene expression proﬁles
were not thoroughly investigated using a quantitative PCR
technique. This will be pursued in the following study.
In conclusion, the results of this study show that ATMSCs
differ from BMMSCs in the osteogenic and chondrogenic
potentials. When equal amount of bioactive factors is given,
the ATMSCs have inferior capacity to differentiate into bone
or cartilage, suggesting the limited utility of ATMSCs as
a source of cells needed for tissue engineering of bone and
cartilage. As a further step forward, a search for the culture
conditions that would induce a successful osteogenesis or
chondrogenesis from ATMSCs is warranted.
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